Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Truthout: Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say
Patients For Affordable Drug’s report, The Rampant Reach of Pharma’s Hidden Hand, details the links between Big Pharma, Seniors 4 Better Care and five more groups, including the Alliance for Aging Research, the Council for Affordable Health Coverage, and the American Action Forum.
News and Reports
Common Dreams: Report Exposes Big Pharma Front Groups Posing as Patient Advocates
Merith Basey, P4AD’s executive director, said that “when your board is stacked with industry insiders, your primary funding comes from pharma, and your talking points mirror those of drug lobbyists, you’re not a patient advocacy organization—you’re a PR operation.” “Polling shows that Americans are aware that pharmaceutical corporations are the primary drivers of high drug […]
News and Reports
CBS News: Can Trump lower prescription drug prices? Here's why U.S. drug costs are so high.
Patients For Affordable Drugs Now, a national patient advocacy organization, said in a statement that several aspects of the Mr. Trump’s order raise questions. “This Executive Order is a step in the right direction, but without additional guardrails, it leaves room for pharmaceutical companies to continue gaming the system at the expense of patients,” the […]
News and Reports
Die Wochenzeitung: Lobby, profit – and do penance
“The pharmaceutical industry is investing more money than ever in lobbying,” says Emma Sands of the patient rights organization Patients for Affordable Drugs. A key goal in recent years has been to prevent drug price controls for Medicare recipients, Sands explains. However, the pharmaceutical industry has recently suffered setbacks in this area. In 2022, the […]
News and Reports
Medium: How Trump’s 2025 Drug Price Gambit Revived an Old Trade Concept
Grassroots movements like #Insulin4All and Patients for Affordable Drugs have shifted public discourse, too, framing access to medicine not as a market good but as a human right. The pressure is building not just to lower prices, but to reimagine pricing itself.
News and Reports
Citeline: Trump’s MFN Executive Order More Rhetoric Than Action
The patient advocacy organization Patients for Affordable Drugs Now (P4ADNow) said that while it supports Trump’s goal, MFN pricing would be better implemented through policy like the Medicare drug price negotiation program. “This executive order is a step in the right direction, but without additional guardrails, it leaves room for pharmaceutical companies to continue gaming […]
News and Reports
Epoch Times: What to Know About Trump’s Plan to Slash Drug Prices
Merith Basey, executive director of Patients for Affordable Drugs, thinks the political moment is right for further action on drug prices. “With this administration, there is an opportunity to build on the existing progress we’ve seen and continue to fight to lower drug prices so that Americans no longer pay more than other high-income countries,” […]
News and Reports
NBC 6 South Florida: Trump signs order to cut some U.S. drug prices
NBC 6 covered yesterday’s announcement of a new Executive Order on drug prices that ties U.S. prices to those in other wealthy countries. But the proposal still leaves room for drug companies to game the system and lacks details on implementation and enforcement.